Real-time enrollment status for this idiopathic pulmonary fibrosis, interstitial lung disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:52 AM UTC
| NCT Number | NCT01915511 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease |
| Phase | Clinical Trial |
| Target Enrollment | 3,000 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Duke University |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 27, 2026: Clinical trial NCT01915511 is currently recruiting participants. This clinical trial study for idiopathic pulmonary fibrosis, interstitial lung disease is actively seeking new participants at 47 locations across the United States. The study is sponsored by Duke University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01915511 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01915511 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.